Hongbing Zhang

12.7k total citations · 4 hit papers
197 papers, 9.2k citations indexed

About

Hongbing Zhang is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Hongbing Zhang has authored 197 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 37 papers in Physiology and 33 papers in Oncology. Recurrent topics in Hongbing Zhang's work include PI3K/AKT/mTOR signaling in cancer (29 papers), Tuberous Sclerosis Complex Research (27 papers) and Cancer, Hypoxia, and Metabolism (12 papers). Hongbing Zhang is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (29 papers), Tuberous Sclerosis Complex Research (27 papers) and Cancer, Hypoxia, and Metabolism (12 papers). Hongbing Zhang collaborates with scholars based in China, United States and United Kingdom. Hongbing Zhang's co-authors include Allan Bradley, David J. Kwiatkowski, Ying Wang, Hiroaki Onda, Thomas P. Neufeld, Christoph Reinhard, Gregor Cicchetti, Francisca Vázquez, Christopher L. Carpenter and Henry Koon and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hongbing Zhang

186 papers receiving 9.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development

1996 776 citations Hongbing Zhang et al. profile →
Regulation of cellular growth by the Drosophila target of rapamycin dTOR

2000 509 citations Hongbing Zhang et al. profile →
Regulation of Autophagy by mTOR Signaling Pathway

2019 261 citations Hongbing Zhang et al. profile →
KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis

2024 134 citations Fangming Liu, Hongbing Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongbing Zhang China	49	5.6k	1.6k	1.5k	1.4k	1.1k	197	9.2k
Andrew R. Tee United Kingdom	39	6.6k 1.2×	970 0.6×	860 0.6×	1.5k 1.1×	917 0.9×	69	9.1k
Leon O. Murphy United States	25	6.6k 1.2×	1.4k 0.9×	1.2k 0.8×	993 0.7×	952 0.9×	31	9.3k
Alejo Efeyan Spain	24	6.0k 1.1×	1.1k 0.7×	1.4k 0.9×	1.9k 1.3×	1.2k 1.1×	49	9.5k
Hirotoshi Tanaka Japan	46	4.2k 0.7×	1.9k 1.2×	1.2k 0.8×	1.0k 0.7×	1.0k 1.0×	175	8.0k
Isabel Fabregat Spain	53	4.8k 0.9×	1.4k 0.9×	2.4k 1.6×	735 0.5×	1.1k 1.0×	168	8.8k
Yuichi Oike Japan	69	6.5k 1.2×	2.5k 1.6×	2.2k 1.5×	1.8k 1.3×	1.4k 1.3×	211	13.1k
Manuel Collado Spain	34	5.8k 1.0×	1.4k 0.9×	2.4k 1.6×	3.2k 2.3×	1.5k 1.4×	78	9.2k
Renhai Cao Sweden	50	5.7k 1.0×	2.8k 1.7×	3.2k 2.2×	1.4k 1.0×	915 0.9×	60	10.1k
Thomas Boettger Germany	45	5.4k 1.0×	2.2k 1.4×	877 0.6×	839 0.6×	613 0.6×	98	8.1k
Richard N. Kitsis United States	54	7.4k 1.3×	1.1k 0.7×	963 0.6×	1.3k 0.9×	900 0.8×	114	11.5k

Countries citing papers authored by Hongbing Zhang

Since Specialization

Citations

This map shows the geographic impact of Hongbing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Zhang more than expected).

Fields of papers citing papers by Hongbing Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Zhang. The network helps show where Hongbing Zhang may publish in the future.

Co-authorship network of co-authors of Hongbing Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbing Zhang. A scholar is included among the top collaborators of Hongbing Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbing Zhang. Hongbing Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lv, Jiacheng, Xinyu Zhang, Lin‐Yan Wan, et al.. (2025). Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment. Cell Death and Disease. 16(1). 42–42. 2 indexed citations

Lu, Xihong, et al.. (2025). Liposome stability: multifactorial regulation and optimization strategies in in vivo delivery. Journal of Liposome Research. 35(4). 607–618.

Zhong, Chuan‐Qi, Kai Huang, Zusen Fan, et al.. (2025). RIPK1 S161 phosphorylation promotes further autophosphorylation and cecal necroptosis in TNF-treated mice. The Journal of Experimental Medicine. 222(12). 2 indexed citations

Lin, Sufang, Qiru Su, Xiaoxiang Tian, et al.. (2025). Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus. Human Vaccines & Immunotherapeutics. 21(1). 2535120–2535120.

Huang, Fuqiang, Jing Guo, Na Zhao, et al.. (2024). PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1. Journal of Translational Medicine. 22(1). 254–254. 4 indexed citations

Zhang, Shaohua, et al.. (2024). Blockchain-Based Data Management and Control System in Rail Transit Security Scenario. 19–23.

Liu, Xinyi, Hongbing Zhang, Jun Xu, et al.. (2019). Identification of absorbed components and their metabolites in rat plasma after oral administration of Shufeng Jiedu capsule using ultra‐performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry. Rapid Communications in Mass Spectrometry. 33(19). 1494–1501. 12 indexed citations

Liu, Zhaoxiang, Jiangfeng Mao, Hongli Xu, et al.. (2019). Gonadotropin-Induced Spermatogenesis in CHH Patients with Cryptorchidism. International Journal of Endocrinology. 2019. 1–6. 16 indexed citations

Sun, Qian, Yanan Wang, Haiyong Peng, et al.. (2018). Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis. Cell Death and Differentiation. 25(6). 1160–1173. 58 indexed citations

10.

He, Jing, Lan Kang, Tong Wu, et al.. (2012). An Elaborate Regulation of Mammalian Target of Rapamycin Activity Is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors. Stem Cells and Development. 21(14). 2630–2641. 43 indexed citations

11.

Chen, Tong, Fei Yan, Jiaming Qian, et al.. (2011). Randomized Phase II Trial of Lyophilized Strawberries in Patients with Dysplastic Precancerous Lesions of the Esophagus. Cancer Prevention Research. 5(1). 41–50. 64 indexed citations

12.

Zha, Xiaojun, Fang Wang, Ying Wang, et al.. (2011). Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis. Cancer Research. 71(1). 13–18. 131 indexed citations

13.

Zhang, Hongbing. (2011). Clinical efficacy of the Qubai Babuqi Tablets in the treatment of vitiligo. 2 indexed citations

14.

Zhang, Hongbing. (2008). Senescence is a defensive mechasim against oncogene-induced tumorigenesis. 1 indexed citations

15.

Zhang, Hongbing, Kevin P. Baker, Ali Sadra, et al.. (2007). FP-1039 (FGFR1:Fc), a soluble FGFR1 receptor antagonist, inhibits tumor growth and angiogenesis. Molecular Cancer Therapeutics. 6. 11 indexed citations

16.

Li, Bing-Zong, Mingxia Shi, Jing Li, et al.. (2007). Elevated Tumor Necrosis Factor- α Suppresses TAZ Expression and Impairs Osteogenic Potential of Flk-1 ⁺ Mesenchymal Stem Cells in Patients with Multiple Myeloma. Stem Cells and Development. 16(6). 921–930. 58 indexed citations

17.

Zhang, Hongbing, et al.. (2004). Perturbed IFN-γ-Jak-Signal Transducers and Activators of Transcription Signaling in Tuberous Sclerosis Mouse Models. Cancer Research. 64(10). 3436–3443. 48 indexed citations

18.

Zhang, Hongbing, et al.. (2003). Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. The Lancet. 361(9366). 1348–1349. 160 indexed citations

19.

Zhang, Hongbing, et al.. (2000). Seven-years follow-up on trial of Interferon alpha in patients with HCV RNA positive chronic hepatitis C. World Journal of Gastroenterology. 6. 114–114. 3 indexed citations

20.

Zhang, Hongbing, et al.. (1998). BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion?. Cell. 92(4). 433–436. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact